The Clinical and Molecular Rersponse of Pyoderma Gangrenosum to Interleukin 23 Blockade: results from a proof-of-concept open-label clinical trial. The Clinical and Molecular Rersponse of Pyoderma Gangrenosum to Interleukin 23 Blockade: results from a proof-of-concept open-label clinical trial
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA1132523
下载链接
链接失效反馈官方服务：
资源简介：
Open Label Clinical Trial Overall design: Tissue Gene Expression Response to Interleukin 23 Blockade of skin biopsies of Pyoderma Gangrenosum at Baseline and Week 12.
创建时间：
2024-07-06
